跳至主要内容
临床试验/ACTRN12608000393358
ACTRN12608000393358已完成4 期

The effect of sodium cromoglycate alone, and in combination with montelukast sodium, on the airway sensitivity and recovery from challenge with inhaled mannitol in subjects with asthma.

Dr. Sandra D. Anderson0 个研究点目标入组 20 人开始时间: 2008年8月4日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
15 Years 至 45 Years(—)
性别
All

入选标准

  • Clinical diagnosis of asthma, FEV1 =70% Predicted; adherent to prescribed ICS (inhaled corticosteroid) therapy for past 4 weeks, no chest infection in last 4 weeks, able to withhold current asthma medication for required time

排除标准

  • pregnant females or those at risk of becoming pregnant, those breast feeding, current smokers or those with a recent (< 1 yr) past history of smoking, known sensitivity to either sodium cromoglycate or montelukast sodium or their components, taking of oral corticosteroids in the last 4 weeks.

研究者

发起方
Dr. Sandra D. Anderson

相似试验